drugset / Trial / NCT07274254
Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to determine whether adding lidocaine to standard of care in pain management during severe vaso-occlusive crisis has an effect on the cumulative opioid consumption expressed as morphine milligram equivalent.
Timeline
- Start
- 2026-07-03
- Primary completion
- 2028-08-03
- Completion
- 2028-08-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 1 mg/kg | Intravenous |